Related Experiment Videos
Estrogen-associated severe hypertriglyceridemia with pancreatitis.
Sumayah Aljenedil1, Robert A Hegele2, Jacques Genest1
1Department of Cardiology and Research Institute, McGill University Health Center, Montreal, Quebec, Canada.
Journal of Clinical Lipidology
|April 11, 2017
Summary
Estrogen therapy can lead to severe hypertriglyceridemia and pancreatitis, a rare but serious condition. Early screening in at-risk individuals is vital for preventing complications.
Area of Science:
- Endocrinology
- Gastroenterology
- Reproductive Medicine
Background:
- Estrogen, in both therapeutic and physiological contexts, is a known cause of hypertriglyceridemia.
- Hypertriglyceridemia-induced pancreatitis is an uncommon but severe complication associated with elevated triglyceride levels.
Observation:
- This report details two cases of women experiencing estrogen-associated severe hypertriglyceridemia complicated by pancreatitis.
- The first patient developed pancreatitis linked to hypertriglyceridemia during in vitro fertilization cycles, responding well to dietary changes and fibrates.
- The second patient developed pancreatitis due to hypertriglyceridemia during pregnancy, with persistent high triglycerides post-delivery due to non-compliance, despite a genetic predisposition.
Findings:
- Neither patient exhibited mutations in known hypertriglyceridemia-associated genes, though the second case suggested polygenic susceptibility.
- Estrogen-induced severe hypertriglyceridemia leading to pancreatitis can be a life-threatening medical emergency.
Implications:
- Identifying and screening high-risk patients for estrogen-induced hypertriglyceridemia is crucial.
- Proactive management and monitoring are essential to prevent severe outcomes like pancreatitis.